Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Meisel

Showing results (141-150 of 310) with videos related to

Pageof 31
Sort By:
Brain and Behavior|September 17, 2025
Anxiety in Myasthenia Gravis Patients Throughout the COVID-19 Pandemic-Prevalence, Risk Factors, and Association With Vaccination StatusJanna Beckmann, Moritz Petzold, Felix Betzler, et al.
Clinical Immunology (Orlando, Fla.)|March 14, 2017
CD4<sup>+</sup> FoxP3<sup>+</sup> T regulatory cell subsets in myasthenia gravis patientsSiegfried Kohler, Thomas Oskar Philipp Keil, Sarah Hoffmann, et al.
Journal of Neurology|April 27, 2023
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extensionAndreas Meisel, Djillali Annane, Tuan Vu, et al.
Stroke|December 7, 2020
External Validation of Five Scores to Predict Stroke-Associated Pneumonia and the Role of Selected Blood BiomarkersBenjamin Hotter, Sarah Hoffmann, Lena Ulm, et al.
BMC Neurology|December 25, 2015
Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot studySarah Hoffmann, Jana Siedler, Alexander U Brandt, et al.
Journal of Neurology|August 12, 2022
Correction to: Burden of disease in myasthenia gravis: taking the patient's perspectiveSophie Lehnerer, Jonas Jacobi, Ralph Schilling, et al.
Neuromuscular Disorders : NMD|February 6, 2023
Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravisSarah Hoffmann, Patrick Waters, Leslie Jacobson, et al.
Stroke|July 17, 2012
Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic strokeSarah Hoffmann, Uwe Malzahn, Hendrik Harms, et al.
Frontiers in Immunology|April 23, 2025
The burden of disease in seronegative myasthenia gravis: a patient-centered perspectiveSophie Lehnerer, Regina Stegherr, Ulrike Grittner, et al.
Journal of Autoimmunity|April 18, 2026
Impact of a ketogenic diet on clinical outcomes and immunological markers in myasthenia gravis: A randomized pilot studyBenjamin Makus, Daniel Schulze, Sophie Lehnerer, et al.
Pageof 31

Showing results (141-150 of 310) with videos related to

Sort By:
Pageof 31
Brain and Behavior|September 17, 2025
Anxiety in Myasthenia Gravis Patients Throughout the COVID-19 Pandemic-Prevalence, Risk Factors, and Association With Vaccination StatusJanna Beckmann, Moritz Petzold, Felix Betzler, et al.
Clinical Immunology (Orlando, Fla.)|March 14, 2017
CD4<sup>+</sup> FoxP3<sup>+</sup> T regulatory cell subsets in myasthenia gravis patientsSiegfried Kohler, Thomas Oskar Philipp Keil, Sarah Hoffmann, et al.
Journal of Neurology|April 27, 2023
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extensionAndreas Meisel, Djillali Annane, Tuan Vu, et al.
Stroke|December 7, 2020
External Validation of Five Scores to Predict Stroke-Associated Pneumonia and the Role of Selected Blood BiomarkersBenjamin Hotter, Sarah Hoffmann, Lena Ulm, et al.
BMC Neurology|December 25, 2015
Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot studySarah Hoffmann, Jana Siedler, Alexander U Brandt, et al.
Journal of Neurology|August 12, 2022
Correction to: Burden of disease in myasthenia gravis: taking the patient's perspectiveSophie Lehnerer, Jonas Jacobi, Ralph Schilling, et al.
Neuromuscular Disorders : NMD|February 6, 2023
Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravisSarah Hoffmann, Patrick Waters, Leslie Jacobson, et al.
Stroke|July 17, 2012
Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic strokeSarah Hoffmann, Uwe Malzahn, Hendrik Harms, et al.
Frontiers in Immunology|April 23, 2025
The burden of disease in seronegative myasthenia gravis: a patient-centered perspectiveSophie Lehnerer, Regina Stegherr, Ulrike Grittner, et al.
Journal of Autoimmunity|April 18, 2026
Impact of a ketogenic diet on clinical outcomes and immunological markers in myasthenia gravis: A randomized pilot studyBenjamin Makus, Daniel Schulze, Sophie Lehnerer, et al.
Pageof 31